ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Emcure Pharmaceuticals will hold a board meeting on August 06, 2026. The board will consider unaudited standalone and consolidated financial results for Q1 FY27.
Emcure Pharmaceuticals Limited has scheduled a Board Meeting for May 5, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 7, 2026.
Emcure Pharmaceuticals Limited has scheduled a Board Meeting for May 5, 2026. The Board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 7, 2026.
Emcure Pharmaceuticals has scheduled a Board Meeting on May 05, 2026. The board will consider audited financial results for the quarter and year ended March 31, 2026, and a final dividend recommendation. The trading window is closed until May 07, 2026.